Key facts
- This page summarizes David G. Gaiero's Form 4 filing for Cyteir Therapeutics, Inc..
- 6 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2024, 18:11.
David G. Gaiero - 29 Feb 2024 Form 4 Insider Report for Cyteir Therapeutics, Inc.
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- N/A
- Reported as of
- 29 Feb 2024
- Net transaction value
- +$17,473
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2024, 18:11:17 UTC
- Prior SEC filing
- 14 Dec 2023
- Next SEC filing
- 16 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Gaiero
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David G. Gaiero filed Form 4 for Cyteir Therapeutics, Inc. on 05 Mar 2024.
Change
- Previous filing in this sequence was filed on 14 Dec 2023.
- Current net transaction value: +$17,473.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYT
transaction
Common Stock
Options Exercise
- Transaction value
- $5,442
- Shares
- +3,239
- Change %
- +3.5%
- Price
- $1.68
- Shares after
- 95,272
- Date
- 29 Feb 2024
- Ownership
- Direct
CYT
transaction
Common Stock
Options Exercise
- Transaction value
- $8,021
- Shares
- +4,746
- Change %
- +5%
- Price
- $1.69
- Shares after
- 100,018
- Date
- 29 Feb 2024
- Ownership
- Direct
CYT
transaction
Common Stock
Options Exercise
- Transaction value
- $4,010
- Shares
- +2,373
- Change %
- +2.4%
- Price
- $1.69
- Shares after
- 102,391
- Date
- 04 Mar 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYT
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,239
- Change %
- -17%
- Price
- $0.000000
- Shares after
- 16,196
- Date
- 29 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,239
- Exercise price
- $1.68
- Footnotes
- F1
CYT
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -4,746
- Change %
- -5.3%
- Price
- $0.000000
- Shares after
- 85,425
- Date
- 29 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,746
- Exercise price
- $1.69
- Footnotes
- F2
CYT
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,373
- Change %
- -2.8%
- Price
- $0.000000
- Shares after
- 83,052
- Date
- 04 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,373
- Exercise price
- $1.69
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The option vested as to 25% of the underlying shares of common stock on December 7, 2021, the first anniversary of the vesting commencement date, and vests as to 1/48th of the underlying shares thereafter on each subsequent monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.
Footnote F2
The option vests as to 1/48th of the underlying shares on each monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.